Literature DB >> 28820513

Predictors of Unplanned Hospitalizations in Patients With Nonmetastatic Lung Cancer During Chemotherapy.

Kristen L Fessele1, Matthew J Hayat2, Robert L Atkins3.   

Abstract

PURPOSE/
OBJECTIVES: To determine predictors of unplanned hospitalizations in patients with lung cancer to receive chemotherapy in the outpatient setting and examine the potential financial burden of these events.
.
DESIGN: Retrospective, longitudinal cohort study.
.
SETTING: The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database.
. SAMPLE: Of 104,388 incident cases of lung cancer diagnosed from 2005-2009, 2,457 cases of patients with lung cancer who received outpatient chemotherapy were identified. Patients were aged 66 years or older at diagnosis, had uninterrupted Medicare Part A and B coverage with no health maintenance organization enrollment, and received IV chemotherapy at least once.
.
METHODS: Generalized estimating equations was used.
. MAIN RESEARCH VARIABLES: Patient age, sex, race, marital status, degree of residential urbanization, median income, education level, stage, receipt of radiation therapy, and comorbidities.
.
FINDINGS: Younger age, non-White race, lower education, higher income, receipt of radiation therapy, and lack of preexisting comorbidity were significant predictors of the likelihood of an initial unplanned hospitalization for lung cancer. Non-White race, receipt of radiation therapy, and comorbidity were factors associated with an increased number of hospitalizations. 
.
CONCLUSIONS: Unplanned hospitalizations are frequent, disruptive, and costly. This article defines areas for further exploration to identify patients at high risk for unexpected complications. 
. IMPLICATIONS FOR NURSING: This article represents a foundation for development of risk models to enable nursing evaluation of patient risk for chemotherapy treatment interruption and unplanned hospitalization.

Entities:  

Keywords:  SEER-Medicare; chemotherapy; comorbidity; hospitalization; lung neoplasms

Mesh:

Substances:

Year:  2017        PMID: 28820513      PMCID: PMC5856246          DOI: 10.1188/17.ONF.E203-E212

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  34 in total

Review 1.  Comorbid disease and cancer: the need for more relevant conceptual models in health services research.

Authors:  Jane M Geraci; Carmen P Escalante; Jean L Freeman; James S Goodwin
Journal:  J Clin Oncol       Date:  2005-10-20       Impact factor: 44.544

2.  Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.

Authors:  Arti Hurria; Kayo Togawa; Supriya G Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Stuart M Lichtman; Ajeet Gajra; Smita Bhatia; Vani Katheria; Shira Klapper; Kurt Hansen; Rupal Ramani; Mark Lachs; F Lennie Wong; William P Tew
Journal:  J Clin Oncol       Date:  2011-08-01       Impact factor: 44.544

Review 3.  Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials.

Authors:  Donna M Zulman; Jeremy B Sussman; Xisui Chen; Christine T Cigolle; Caroline S Blaum; Rodney A Hayward
Journal:  J Gen Intern Med       Date:  2011-02-01       Impact factor: 5.128

4.  Preventing avoidable rehospitalizations by understanding the characteristics of "frequent fliers".

Authors:  Barbara J Mulder; Huey-Ming Tzeng; Nancy D Vecchioni
Journal:  J Nurs Care Qual       Date:  2012 Jan-Mar       Impact factor: 1.597

5.  Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer.

Authors:  Michael J Hassett; A James O'Malley; Juliana R Pakes; Joseph P Newhouse; Craig C Earle
Journal:  J Natl Cancer Inst       Date:  2006-08-16       Impact factor: 13.506

6.  Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer.

Authors:  Vijaya Sundararajan; Nandita Mitra; Judith S Jacobson; Victor R Grann; Daniel F Heitjan; Alfred I Neugut
Journal:  Ann Intern Med       Date:  2002-03-05       Impact factor: 25.391

7.  Risk of hospitalizations associated with adverse effects of chemotherapy in a large community-based cohort of elderly women with ovarian cancer.

Authors:  Zhannat Nurgalieva; Chih-Chin Liu; Xianglin L Du
Journal:  Int J Gynecol Cancer       Date:  2009-11       Impact factor: 3.437

8.  The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer.

Authors:  Cary P Gross; Gail J McAvay; Zhenchao Guo; Mary E Tinetti
Journal:  Cancer       Date:  2007-06-15       Impact factor: 6.860

9.  A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.

Authors:  Carrie N Klabunde; Julie M Legler; Joan L Warren; Laura-Mae Baldwin; Deborah Schrag
Journal:  Ann Epidemiol       Date:  2007-05-25       Impact factor: 3.797

10.  Why do patients with cancer visit emergency departments? Results of a 2008 population study in North Carolina.

Authors:  Deborah K Mayer; Debbie Travers; Annah Wyss; Ashley Leak; Anna Waller
Journal:  J Clin Oncol       Date:  2011-05-23       Impact factor: 44.544

View more
  3 in total

1.  Development and Validation of a Score to Predict Acute Care Use After Initiation of Systemic Therapy for Cancer.

Authors:  Robert C Grant; Rahim Moineddin; Zhan Yao; Melanie Powis; Vishal Kukreti; Monika K Krzyzanowska
Journal:  JAMA Netw Open       Date:  2019-10-02

2.  Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impact.

Authors:  Sarah Z Hazell; Nicholas Mai; Wei Fu; Chen Hu; Cole Friedes; Alex Negron; Khinh Ranh Voong; Josephine L Feliciano; Peijin Han; Samantha Myers; Todd R McNutt; Russell K Hales
Journal:  BMC Cancer       Date:  2020-04-19       Impact factor: 4.430

3.  Association of Prognostic Understanding With Health Care Use Among Older Adults With Advanced Cancer: A Secondary Analysis of a Cluster Randomized Clinical Trial.

Authors:  Kah Poh Loh; Christopher L Seplaki; Chandrika Sanapala; Reza Yousefi-Nooraie; Jennifer L Lund; Ronald M Epstein; Paul R Duberstein; Marie Flannery; Eva Culakova; Huiwen Xu; Colin McHugh; Heidi D Klepin; Po-Ju Lin; Erin Watson; Valerie Aarne Grossman; Jane Jijun Liu; Jodi Geer; Mark A O'Rourke; Karen Mustian; Supriya G Mohile
Journal:  JAMA Netw Open       Date:  2022-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.